Fundai

Iran Injectable Products Company (DEFRA) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DEFRA
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations8,390,6074,014,0832,353,8602,905,6341,568,856885,525
Cash payments for income tax-881,820-822,099-530,813-464,636-201,093-165,412
Net cash inflow (outflow) from operating activities7,508,7873,191,9841,823,0472,440,9981,367,763720,113
Cash payments for purchase of property, plant and equipment-356,310-202,091-287,135-631,314-194,884-35,801
Cash receipts from sale of long-term investments310,0001,680,000245,0001,972,20000
Cash payments for acquisition of long-term investments-5,005,000-2,790,000-585,000-3,130,200-1,125,0000
Cash receipts from sale of short-term investments320,0000250,000576,0001,267,6250
Cash payments for acquisition of short-term investments-1,603,0000-100,000-300,000-565,000-426,984
Cash receipts from interest on other investments1,429,583276,139120,695275,285196,20441,966
Net cash inflow (outflow) from investing activities-4,904,727-1,035,952-356,440-1,238,029-423,174-420,819
Net cash inflow (outflow) before financing activities2,604,0602,156,0321,466,6071,202,969944,589299,294
Cash receipts from sale of treasury shares32,58500000
Cash payments for dividends-1,601,371-2,057,571-1,279,330-1,378,520-828,040-163,085
Net cash inflow (outflow) from financing activities-1,568,786-2,057,571-1,279,330-1,378,520-828,040-163,085
Net increase (decrease) in cash1,035,27498,461187,277-175,551116,549136,209
Cash balance at beginning of year1,449,440720,730312,098977,769161,35160,430
Effect of changes in exchange rates-1,0330-43000
Cash balance at end of year2,483,681819,191499,332802,218277,900196,639

Reporting periods

77 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.